Recurrent, locally advanced Nasopharyngeal Carcinoma (NPC)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15043 | Toripalimab | A PD-1 blocking monoclonal antibody used for the treatment of metastatic and recurrent nasopharyngeal carcinomas. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB15043 | Toripalimab | Programmed cell death protein 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|